1. Home
  2. PGRU vs EVO Comparison

PGRU vs EVO Comparison

Compare PGRU & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGRU
  • EVO
  • Stock Information
  • Founded
  • PGRU 2006
  • EVO 1993
  • Country
  • PGRU Singapore
  • EVO Germany
  • Employees
  • PGRU N/A
  • EVO N/A
  • Industry
  • PGRU EDP Services
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • PGRU Technology
  • EVO Health Care
  • Exchange
  • PGRU Nasdaq
  • EVO Nasdaq
  • Market Cap
  • PGRU 1.1B
  • EVO 1.1B
  • IPO Year
  • PGRU N/A
  • EVO 2021
  • Fundamental
  • Price
  • PGRU $6.64
  • EVO $5.44
  • Analyst Decision
  • PGRU Buy
  • EVO Buy
  • Analyst Count
  • PGRU 2
  • EVO 2
  • Target Price
  • PGRU $7.00
  • EVO $5.90
  • AVG Volume (30 Days)
  • PGRU 111.9K
  • EVO 362.8K
  • Earning Date
  • PGRU 11-26-2024
  • EVO 11-06-2024
  • Dividend Yield
  • PGRU N/A
  • EVO N/A
  • EPS Growth
  • PGRU N/A
  • EVO N/A
  • EPS
  • PGRU N/A
  • EVO N/A
  • Revenue
  • PGRU $116,419,914.00
  • EVO $866,665,179.00
  • Revenue This Year
  • PGRU $14.24
  • EVO $4.56
  • Revenue Next Year
  • PGRU $18.14
  • EVO $13.44
  • P/E Ratio
  • PGRU N/A
  • EVO N/A
  • Revenue Growth
  • PGRU 9.47
  • EVO N/A
  • 52 Week Low
  • PGRU $3.15
  • EVO $2.85
  • 52 Week High
  • PGRU $6.65
  • EVO $12.00
  • Technical
  • Relative Strength Index (RSI)
  • PGRU 59.61
  • EVO 69.82
  • Support Level
  • PGRU $6.61
  • EVO $4.34
  • Resistance Level
  • PGRU $6.65
  • EVO $4.95
  • Average True Range (ATR)
  • PGRU 0.02
  • EVO 0.21
  • MACD
  • PGRU -0.00
  • EVO 0.12
  • Stochastic Oscillator
  • PGRU 75.00
  • EVO 89.72

About PGRU PropertyGuru Group Limited

PropertyGuru Group Ltd is a property technology company. The company provides digital property marketplaces to match buyers and tenants with sellers and landlords, digital marketing services for property agents and developers, SaaS-based sales process automation for property developers, a digital mortgage marketplace and brokerage, and property data consultancy services for banks, valuers and property developers. Their operating segments and reportable segments are each of its four marketplaces, Singapore, Vietnam, Malaysia and Other Asia, and Fintech and data services.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: